Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation

Summary

This study is designed to see if the use of the drug Sitagliptin (used to reduce insulin resistance) will delay or prevent kidney transplant patients from getting diabetes.

Timeline

Start

2009-07-06

Primary completion

2010-05-01

Completion

2010-06-01

Outcome

Outcome not reported

Stopped (Business): “lack of funding”

Publications

• Background Lane JT, Odegaard DE, Haire CE, Collier DS, Wrenshall LE, Stevens RB. Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation. Transplantation. 2011 Nov 27;92(10):e56-7. doi: 10.1097/TP.0b013e3182347ea4. No abstract available.

Drugs

Indications